UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION
12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number 000-51314          
Winston Pharmaceuticals, Inc.
 
(Exact name of registrant as specified in its charter)
100 North Fairway Drive, Suite 134
Vernon Hills, IL, 60061
Tel: (847) 862-8200
 
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Common Stock, $0.001 par value per share
 
(Title of each class of securities covered by this Form)
None
 
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
     
Rule 12g-4(a)(1)
  o  
Rule 12g-4(a)(2)
  þ  
Rule 12h-3(b)(1)(i)
  o  
Rule 12h-3(b)(1)(ii)
  þ  
Rule 15d-6
  o  
Approximate number of holders of record as of the certification or notice date: 450                    
Pursuant to the requirements of the Securities Exchange Act of 1934, Winston Pharmaceuticals, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
         
     
Date: June 1, 2010   By   /s/ Joel E. Bernstein    
    Joel E. Bernstein, M.D.   
    President and Chief Executive Officer   
 
Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.
 
 

 

Grafico Azioni Winston Pharmaceuticals (CE) (USOTC:WPHM)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Winston Pharmaceuticals (CE)
Grafico Azioni Winston Pharmaceuticals (CE) (USOTC:WPHM)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Winston Pharmaceuticals (CE)